First Time Loading...

RemeGen Co Ltd
HKEX:9995

Watchlist Manager
RemeGen Co Ltd Logo
RemeGen Co Ltd
HKEX:9995
Watchlist
Price: 31.4 HKD -2.79% Market Closed
Updated: May 12, 2024

RemeGen Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

RemeGen Co Ltd
Operating Income Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
RemeGen Co Ltd
HKEX:9995
Operating Income
-¥1.5B
CAGR 3-Years
-31%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Income
-¥8.8B
CAGR 3-Years
8%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
-¥1.1B
CAGR 3-Years
-36%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
¥1.4B
CAGR 3-Years
22%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
¥8.7B
CAGR 3-Years
25%
CAGR 5-Years
34%
CAGR 10-Years
53%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Income
¥1.4B
CAGR 3-Years
59%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is RemeGen Co Ltd's Operating Income?
Operating Income
-1.5B CNY

Based on the financial report for Dec 31, 2023, RemeGen Co Ltd's Operating Income amounts to -1.5B CNY.

What is RemeGen Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-46%

Over the last year, the Operating Income growth was -41%. The average annual Operating Income growth rates for RemeGen Co Ltd have been -31% over the past three years , -46% over the past five years .